UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by MPS Loria Financial Planners LLC

Posted by Defense World Staff on Jun 23rd, 2023

MPS Loria Financial Planners LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 1.6% in the first quarter, according to its most recent filing with the SEC. The fund owned 7,077 shares of the healthcare conglomerate’s stock after acquiring an additional 110 shares during the period. UnitedHealth Group comprises about 1.4% of MPS Loria Financial Planners LLC’s portfolio, making the stock its 6th largest holding. MPS Loria Financial Planners LLC’s holdings in UnitedHealth Group were worth $3,344,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently modified their holdings of UNH. Moneta Group Investment Advisors LLC lifted its holdings in shares of UnitedHealth Group by 100,076.4% in the fourth quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock valued at $6,268,753,000 after purchasing an additional 11,812,017 shares in the last quarter. Norges Bank purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at $5,210,004,000. Arrowstreet Capital Limited Partnership increased its stake in shares of UnitedHealth Group by 1,682.4% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock worth $1,372,606,000 after acquiring an additional 2,540,538 shares during the last quarter. Morgan Stanley increased its stake in shares of UnitedHealth Group by 13.8% in the fourth quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate’s stock worth $8,289,386,000 after acquiring an additional 1,893,192 shares during the last quarter. Finally, Vanguard Group Inc. increased its stake in shares of UnitedHealth Group by 1.0% in the third quarter. Vanguard Group Inc. now owns 82,969,869 shares of the healthcare conglomerate’s stock worth $41,903,103,000 after acquiring an additional 851,994 shares during the last quarter. Institutional investors and hedge funds own 92.61% of the company’s stock.

UnitedHealth Group Stock Up 0.5 %

NYSE UNH opened at $479.19 on Friday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.81 and a current ratio of 0.81. The firm has a 50-day simple moving average of $485.88 and a 200 day simple moving average of $493.04. UnitedHealth Group Incorporated has a twelve month low of $445.68 and a twelve month high of $558.10. The stock has a market cap of $446.14 billion, a PE ratio of 21.91, a PEG ratio of 1.34 and a beta of 0.68.

UnitedHealth Group (NYSE:UNH – Get Rating) last announced its quarterly earnings results on Friday, April 14th. The healthcare conglomerate reported $6.26 EPS for the quarter, topping analysts’ consensus estimates of $6.24 by $0.02. The firm had revenue of $91.93 billion during the quarter, compared to analysts’ expectations of $89.77 billion. UnitedHealth Group had a net margin of 6.16% and a return on equity of 27.05%. The company’s revenue for the quarter was up 14.7% compared to the same quarter last year. During the same quarter last year, the company earned $5.49 earnings per share. On average, research analysts forecast that UnitedHealth Group Incorporated will post 24.86 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 27th. Shareholders of record on Monday, June 19th will be paid a dividend of $1.88 per share. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.65. The ex-dividend date of this dividend is Thursday, June 15th. This represents a $7.52 dividend on an annualized basis and a yield of 1.57%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 34.39%.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the stock. Stephens reaffirmed an “overweight” rating and issued a $605.00 price target on shares of UnitedHealth Group in a research note on Tuesday, February 28th. Oppenheimer reissued an “outperform” rating and set a $610.00 target price on shares of UnitedHealth Group in a research report on Monday, April 17th. SVB Securities lowered their target price on shares of UnitedHealth Group from $625.00 to $560.00 in a research report on Wednesday, June 14th. StockNews.com downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, June 14th. Finally, Deutsche Bank Aktiengesellschaft lowered their target price on shares of UnitedHealth Group from $627.00 to $564.00 in a research report on Friday, June 16th. One analyst has rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $592.68.

Insiders Place Their Bets

In other news, EVP Erin Mcsweeney sold 1,008 shares of the firm’s stock in a transaction that occurred on Friday, April 21st. The shares were sold at an average price of $484.58, for a total transaction of $488,456.64. Following the completion of the sale, the executive vice president now owns 10,359 shares of the company’s stock, valued at $5,019,764.22. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. In other news, CEO Andrew Witty sold 6,160 shares of the firm’s stock in a transaction that occurred on Thursday, April 27th. The shares were sold at an average price of $487.49, for a total transaction of $3,002,938.40. Following the completion of the sale, the chief executive officer now owns 86,564 shares of the company’s stock, valued at $42,199,084.36. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Erin Mcsweeney sold 1,008 shares of the firm’s stock in a transaction that occurred on Friday, April 21st. The shares were sold at an average price of $484.58, for a total transaction of $488,456.64. Following the completion of the sale, the executive vice president now directly owns 10,359 shares of the company’s stock, valued at approximately $5,019,764.22. The disclosure for this sale can be found here. Insiders sold a total of 8,852 shares of company stock worth $4,313,962 over the last quarter. Company insiders own 0.35% of the company’s stock.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.